Singapore markets closed

Phathom Pharmaceuticals, Inc. (PHAT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
9.02-0.08 (-0.88%)
As of 10:42AM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
682
682
0
0
0
Cost of revenue
167
167
0
-
-
Gross profit
515
515
0
-
-
Operating expenses
Research development
49,899
49,899
71,441
72,338
98,148
Selling general and administrative
117,928
117,928
100,999
62,742
27,517
Total operating expenses
167,827
167,827
172,440
135,080
125,665
Operating income or loss
-167,312
-167,312
-172,440
-135,080
-125,665
Interest expense
41,968
41,968
27,305
6,788
4,581
Total other income/expenses net
-188
-188
-110
-2,056
87
Income before tax
-201,592
-201,592
-197,723
-143,883
-129,068
Income from continuing operations
-201,592
-201,592
-197,723
-143,883
-129,068
Net income
-201,592
-201,592
-197,723
-143,883
-129,068
Net income available to common shareholders
-201,592
-201,592
-197,723
-143,883
-129,068
Basic EPS
-3.81
-
-5.05
-3.89
-3.88
Diluted EPS
-3.81
-
-5.05
-3.89
-3.88
Basic average shares
47,283
-
39,118
37,003
33,228
Diluted average shares
47,283
-
39,118
37,003
33,228